doi: 10.5281/zenodo.19834057
Clinical trial NCT05574400 tests caffeine for postoperative delirium. Caffeine's adenosine receptor antagonism could prevent delirium-associated cognitive decline. Low-cost intervention could reduce progression to dementia in surgical patients.